316 related articles for article (PubMed ID: 30076101)
21. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.
Gristick HB; von Boehmer L; West AP; Schamber M; Gazumyan A; Golijanin J; Seaman MS; Fätkenheuer G; Klein F; Nussenzweig MC; Bjorkman PJ
Nat Struct Mol Biol; 2016 Oct; 23(10):906-915. PubMed ID: 27617431
[TBL] [Abstract][Full Text] [Related]
22. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.
Cottrell CA; Hu X; Lee JH; Skog P; Luo S; Flynn CT; McKenney KR; Hurtado J; Kalyuzhniy O; Liguori A; Willis JR; Landais E; Raemisch S; Chen X; Baboo S; Himansu S; Diedrich JK; Duan H; Cheng C; Schiffner T; Bader DLV; Kulp DW; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Sincomb T; Kubitz M; Mullen TM; Yates JR; Paulson JC; Mascola JR; Alt FW; Briney B; Sok D; Schief WR
Sci Transl Med; 2024 May; 16(748):eadn0223. PubMed ID: 38753806
[TBL] [Abstract][Full Text] [Related]
23. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.
Sundling C; Li Y; Huynh N; Poulsen C; Wilson R; O'Dell S; Feng Y; Mascola JR; Wyatt RT; Karlsson Hedestam GB
Sci Transl Med; 2012 Jul; 4(142):142ra96. PubMed ID: 22786681
[TBL] [Abstract][Full Text] [Related]
24. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.
Lin YR; Parks KR; Weidle C; Naidu AS; Khechaduri A; Riker AO; Takushi B; Chun JH; Borst AJ; Veesler D; Stuart A; Agrawal P; Gray M; Pancera M; Huang PS; Stamatatos L
Immunity; 2020 Oct; 53(4):840-851.e6. PubMed ID: 33053332
[TBL] [Abstract][Full Text] [Related]
26. Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
Rao PG; Lambert GS; Upadhyay C
J Virol; 2023 Sep; 97(9):e0071023. PubMed ID: 37681958
[TBL] [Abstract][Full Text] [Related]
27. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.
Sok D; Briney B; Jardine JG; Kulp DW; Menis S; Pauthner M; Wood A; Lee EC; Le KM; Jones M; Ramos A; Kalyuzhniy O; Adachi Y; Kubitz M; MacPherson S; Bradley A; Friedrich GA; Schief WR; Burton DR
Science; 2016 Sep; 353(6307):1557-1560. PubMed ID: 27608668
[TBL] [Abstract][Full Text] [Related]
28. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
29. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
Hoot S; McGuire AT; Cohen KW; Strong RK; Hangartner L; Klein F; Diskin R; Scheid JF; Sather DN; Burton DR; Stamatatos L
PLoS Pathog; 2013 Jan; 9(1):e1003106. PubMed ID: 23300456
[TBL] [Abstract][Full Text] [Related]
30. Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.
Liu Q; Zhang P; Miao H; Lin Y; Kwon YD; Kwong PD; Rikhtegaran-Tehrani Z; Seaman MS; DeVico AL; Sajadi MM; Lusso P
J Virol; 2021 May; 95(12):. PubMed ID: 33827946
[TBL] [Abstract][Full Text] [Related]
31. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
Crooks ET; Tong T; Chakrabarti B; Narayan K; Georgiev IS; Menis S; Huang X; Kulp D; Osawa K; Muranaka J; Stewart-Jones G; Destefano J; O'Dell S; LaBranche C; Robinson JE; Montefiori DC; McKee K; Du SX; Doria-Rose N; Kwong PD; Mascola JR; Zhu P; Schief WR; Wyatt RT; Whalen RG; Binley JM
PLoS Pathog; 2015 May; 11(5):e1004932. PubMed ID: 26023780
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.
Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB
PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308
[TBL] [Abstract][Full Text] [Related]
33. Rational HIV immunogen design to target specific germline B cell receptors.
Jardine J; Julien JP; Menis S; Ota T; Kalyuzhniy O; McGuire A; Sok D; Huang PS; MacPherson S; Jones M; Nieusma T; Mathison J; Baker D; Ward AB; Burton DR; Stamatatos L; Nemazee D; Wilson IA; Schief WR
Science; 2013 May; 340(6133):711-6. PubMed ID: 23539181
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a VRC01-like antibody lineage with immature V
Hu Y; Li D; Yuan Z; Feng Y; Ren L; Hao Y; Wang S; Hu X; Liu Y; Hong K; Shao Y; Wang Z
Mol Immunol; 2023 Feb; 154():11-23. PubMed ID: 36577292
[TBL] [Abstract][Full Text] [Related]
35. Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.
Dubrovskaya V; Guenaga J; de Val N; Wilson R; Feng Y; Movsesyan A; Karlsson Hedestam GB; Ward AB; Wyatt RT
PLoS Pathog; 2017 Sep; 13(9):e1006614. PubMed ID: 28902916
[TBL] [Abstract][Full Text] [Related]
36. CD4-Induced Antibodies Promote Association of the HIV-1 Envelope Glycoprotein with CD4-Binding Site Antibodies.
Gardner MR; Fellinger CH; Prasad NR; Zhou AS; Kondur HR; Joshi VR; Quinlan BD; Farzan M
J Virol; 2016 Sep; 90(17):7822-32. PubMed ID: 27334589
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.
Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR
Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Zhou T; Georgiev I; Wu X; Yang ZY; Dai K; Finzi A; Kwon YD; Scheid JF; Shi W; Xu L; Yang Y; Zhu J; Nussenzweig MC; Sodroski J; Shapiro L; Nabel GJ; Mascola JR; Kwong PD
Science; 2010 Aug; 329(5993):811-7. PubMed ID: 20616231
[TBL] [Abstract][Full Text] [Related]
40. Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan.
Umotoy J; Bagaya BS; Joyce C; Schiffner T; Menis S; Saye-Francisco KL; Biddle T; Mohan S; Vollbrecht T; Kalyuzhniy O; Madzorera S; Kitchin D; Lambson B; Nonyane M; Kilembe W; ; ; Poignard P; Schief WR; Burton DR; Murrell B; Moore PL; Briney B; Sok D; Landais E
Immunity; 2019 Jul; 51(1):141-154.e6. PubMed ID: 31315032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
